💊

Trisenox

arsenic trioxide

Akut promyelocytleukemi

✅ Auktoriserad

✅

Inga aktiva aviseringar

Denna medicin har inga pågående brister, säkerhetsbrev eller återkallelser.

Vad det används till

Trisenox is indicated for induction of remission, and consolidation in adult patients with: Newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL) (white blood cell count, ? 10 x 103/µl) in combination with all?trans?retinoic acid (ATRA) Relapsed/refractory acute promyelocytic leukaemia (APL) (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the Pro-Myelocytic Leukaemia/Retinoic-Acid-Receptor-alpha (PML/RAR-alpha) gene. The response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.

⚠️ Patientsäkerhet

📚 Tidigare aviseringar (2)

Medium EU löst för 8 år sedan

Trisenox

Trisenox Verksamt ämne: arseniktrioxid Former: Infusionsvätska Användningsområde: Akut promyelocytleukemi Finns andra alternativ

Medium EU löst för 8 år sedan

Trisenox

INN: arsenic trioxide · Forms: Solution for infusion · Area: Leukemia, Promyelocytic, Acute · Alternatives: Yes

Officiell EMA-sida

https://www.ema.europa.eu/en/medicines/human/EPAR/trisenox